This announcement is a separate document:
明德生物：关于2023年度计提资产减值准备的公告
Matilda Biotech: Announcement on preparation for asset impairment in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.